Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.
Biochem Biophys Res Commun. 2010 Dec 3;403(1):154-9. doi: 10.1016/j.bbrc.2010.11.007. Epub 2010 Nov 6.
Ovarian carcinomas are often highly invasive, especially in the peritoneal cavity; however, the mechanism involved in invasion is not yet fully understood. In the present research, we studied the role of NF-κB in the invasiveness of ovarian carcinoma cells by using (-)-DHMEQ, a specific inhibitor of NF-κB. (-)-DHMEQ inhibited invasion in vitro and the expression of CXCL12 and CXCR4. We found that neutralizing antibody against CXCR4 or knockdown of CXCR4 suppressed the invasion. Proteomic analysis revealed that CXCR4-siRNA treatment lowered the secretion of several invasion-related proteins, such as MMP-9 and uPA. These data imply that (-)-DHMEQ suppressed ovarian cell invasion via inhibition of the NF-κB-regulated autocrine system of CXCL12-CXCR4.
卵巢癌通常具有高度侵袭性,尤其是在腹腔内;然而,其侵袭机制尚不完全清楚。在本研究中,我们通过使用 NF-κB 的特异性抑制剂 (-)-DHMEQ 来研究 NF-κB 在卵巢癌细胞侵袭中的作用。(-)-DHMEQ 抑制了体外侵袭和 CXCL12 和 CXCR4 的表达。我们发现,针对 CXCR4 的中和抗体或 CXCR4 的敲低抑制了侵袭。蛋白质组学分析显示,CXCR4-siRNA 处理降低了几种侵袭相关蛋白的分泌,如 MMP-9 和 uPA。这些数据表明,(-)-DHMEQ 通过抑制 NF-κB 调节的 CXCL12-CXCR4 自分泌系统来抑制卵巢癌细胞的侵袭。